Efficacy and Safety of Ilaprazole for GERD: A Randomized,Double-Blind, Esomeprazole-Controlled,Phase2,Multicenter Trial in China.

Trial Profile

Efficacy and Safety of Ilaprazole for GERD: A Randomized,Double-Blind, Esomeprazole-Controlled,Phase2,Multicenter Trial in China.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Ilaprazole (Primary) ; Esomeprazole
  • Indications Gastro-oesophageal reflux
  • Focus Therapeutic Use
  • Sponsors Livzon Group
  • Most Recent Events

    • 07 Sep 2016 Primary endpoint (The proportion of patients with healed esophagitis at week 8) has not been met ,according to the results published in the Clinical Drug Investigation .
    • 07 Sep 2016 Results published in the Clinical Drug Investigation (2016).
    • 22 Apr 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top